Vinorelbine Tartrate Injection
| General Information: Vinorelbine is typically utilized for the treatment of advanced nonsmall cell lung cancer. For indication, dosing or other information, please refer to the manufacture package insert. |
| |
| Manufacturer |
Product |
SIze |
NDC |
PI |
MSDS |
| Sagent |
Vinorelbine |
10mg/mL |
25201-0204-01 |
PI |
MSDS |
| |
|
50mg/5mL |
25201-0204-05 |
PI |
MSDS |
| Hospira |
Vinorelbine Tartrate
INJ |
10mg/1mL |
61703-0341-06 |
PI |
MSDS |
| |
Vinorelbine Tartrate
INJ |
50mg/5mL |
61703-0341-09 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Vinorelbine Tartrate
Injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |